Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines Congrui ZhuShengmei PangQiangde Duan Review Article 23 April 2024
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease David Valdés-AriasElyana V. T. LocatelliAnat Galor Review Article Open access 23 April 2024
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Sarah E. ThomasLiana BarenbrugJuul M. P. A. van den Reek Systematic Review Open access 17 April 2024
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders Vito D’AgnanoDomenica Francesca MarinielloFabio Perrotta Leading Article Open access 17 April 2024
Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo Connie Kang Adis Drug Evaluation 16 April 2024
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments Javier Torres-JiménezJavier Baena EspinarLuis Paz-Ares Review Article 16 April 2024
Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain Hannah A. Blair Adis Drug Evaluation 09 April 2024
The Pharmacological Landscape for Fatty Change of the Pancreas Maxim S. Petrov Leading Article Open access 04 April 2024
Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease Amy Zhuang-YanYahiya Y. Syed Adis Drug Evaluation 30 March 2024
Correction: Zilucoplan: First Approval Matt Shirley Correction Open access 19 March 2024 Pages: 373 - 373
Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1 Connie Kang Correction Open access 15 March 2024 Pages: 371 - 371
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability Alise K. CarlsonMoein AminJeffrey A. Cohen Review Article Open access 14 March 2024 Pages: 285 - 304
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects? Sanne M. BuijsStijn L. W. KoolenAgnes Jager Review Article Open access 14 March 2024
Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials Yifan WangHe YiLing Li Systematic Review 13 March 2024
Opioids for Acute Musculoskeletal Pain: A Systematic Review with Meta-Analysis Caitlin M. P. JonesAili LangfordChung-Wei Christine Lin Systematic Review Open access 07 March 2024 Pages: 305 - 317
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection Hannah A. Blair Adis Drug Evaluation 05 March 2024 Pages: 329 - 336
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options Sara BindoliChiara BaggioPaolo Sfriso Review Article Open access 05 March 2024 Pages: 257 - 274
Microencapsulated Benzoyl Peroxide for Rosacea in Context: A Review of the Current Treatment Landscape Seemal R. DesaiHilary BaldwinLinda Stein Gold Review Article Open access 29 February 2024 Pages: 275 - 284
A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder Michael A. NorredZachary D. ZuschlagMark B. Hamner Review Article 28 February 2024 Pages: 149 - 164
Berdazimer Topical Gel, 10.3%: First Approval Susan J. Keam AdisInsight Report 27 February 2024 Pages: 363 - 368
Tirzepatide: A Review in Type 2 Diabetes Nicole L. FranceYahiya Y. Syed Adis Drug Evaluation 23 February 2024 Pages: 227 - 238
Vonoprazan: A Review in Helicobacter pylori Infection Matt Shirley Adis Drug Evaluation 23 February 2024 Pages: 319 - 327
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression Kamyar KeramatianTrisha ChakrabartyLakshmi N. Yatham Correction 12 February 2024 Pages: 369 - 369
Methadone for Cancer Pain Management in Children: A Review of Literature Sebastiano Mercadante Review Article 07 February 2024 Pages: 203 - 208
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature Willemijn A. M. SchonckErik S. G. StroesLaurens F. Reeskamp Review Article Open access 25 January 2024 Pages: 165 - 178
Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota Linhai CaoHongxia NiHui Chang Review Article 24 January 2024 Pages: 179 - 202
Correction to: Nedosiran: First Approval Yahiya Y. Syed Correction Open access 22 January 2024 Pages: 255 - 255
Lumasiran: A Review in Primary Hyperoxaluria Type 1 Connie Kang Adis Drug Evaluation Open access 22 January 2024 Pages: 219 - 226
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry Jonathan SchimmelLindsey Claire Eppersonthe Toxicology Investigators Consortium FACT Study Group Original Research Article 10 January 2024 Pages: 209 - 217
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges Camille AllardDaniela CotaCarmelo Quarta Review Article 21 December 2023 Pages: 127 - 148
Spesolimab for the Treatment of Generalized Pustular Psoriasis Diana BernardoDiamant ThaçiTiago Torres Review Article Open access 20 December 2023 Pages: 45 - 58
Reply to the Comments on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Thomas Yen-Ting ChenQianru ZhangJames Cheng-Chung Wei Letter to the Editor 18 December 2023 Pages: 123 - 125
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Wen-Bin YehWei-Kai LeeCheuk-Kwan Sun Letter to the Editor 18 December 2023 Pages: 121 - 122
Comment on: “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study” Tsung-Wei ChangCheng-Hsien Hung Letter to the Editor 18 December 2023 Pages: 119 - 120
Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies Bennett A. CaugheyJohn H. Strickler Review Article 18 December 2023 Pages: 27 - 44
